Dr. Ibrahim Elali, MD

Dr. Elali practices at Trc Harbor UCLA Mfi Total Renal Dialysis Center in Torrance, California.

Dr. Elali's NPI, 1932141421, was assigned on June 11, 2006. Dr. Elali graduated from Kaunas Univ Med in 1998. Dr. Elali's Minnesota license number on file is 71407.

Dr. Elali's primary practice is Trc Harbor UCLA Mfi Total Renal Dialysis Center, at 21836 Normandie Ave, Torrance, CA 90502 in Los Angeles County. The practice phone is (310) 533-0413.

Dr. Elali's primary practice is Trc Harbor UCLA Mfi Total Renal Dialysis Center in Torrance, California. Dr. Elali is also affiliated with Harbor-UCLA Medical Center. The medical group on file is ProHealth Partners. Dmand AI also links Dr. Elali to 1 more hospital, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elali practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Elali's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Elali is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Elali's licenses on file in 4 states: Minnesota, California, Connecticut and Virginia.

CMS data shows 39 Medicare services from Dr. Elali across 2 procedure codes in 2023, all of them office visits, for 11 Medicare patients. Medicare paid $2,282 for them. Every service was in an office.

CMS counts 11 Medicare patients who saw Dr. Elali in 2024. The largest group is 85 and over, with 0 patients. 100% are also on Medicaid. Their average risk score is 7.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elali's median patient age at 59, with 32% women.

In 2024, Dr. Elali wrote 249 Medicare Part D claims for 42 patients. 92% of them were for generic drugs. CMS names the drug for 130 of them, across 8 drugs with 11 or more claims each, at $8,068 in total drug cost. In 2023, CMS named 37 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Dr. Elali for performance year 2024, reported as part of a group. Dr. Elali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Elali, published from 2021 to 2025. 2021 was the busiest year, with 2. The most frequent topics are Plasma Exchange, Filtration and Heparin. Dr. Elali has published most often in J Clin Apher. Dr. Elali's most frequent co-authors are Kamyar Zadeh Kalantar-Zadeh, MD, Csaba Pal Kovesdy, MD and Connie Meeyoung Rhee, MD.

CMS Open Payments shows 25 general payments to Dr. Elali from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $171.

Dr. Elali graduated from Kaunas Univ Med in 1998. Dr. Elali is a member of ACP, ASFA, ASN, American Society of Transplantation AST and National Kidney Foundation NKF.

Dr. Elali is in network with 10 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.